WJCD  Vol.5 No.5 , May 2015
Cardiac Autonomic Control in Relation to Other Prognostic Markers in Idiopathic Dilated Cardiomyopathy
ABSTRACT
Objectives: We set out to study cardiac autonomic tone in patients with idiopathic dilated cardio-myopathy (IDC), and whether it correlates with other established markers of disease progression and patient ultimate outcome. Design: Fifty-one IDC patients in sinus rhythm underwent extensive non-invasive and invasive evaluation during a three-day hospitalization period. The control group consisted of thirty-eight apparently healthy subjects who underwent 24-hour ambulatory ECG recording. Results: Heart rate variability (HRV) and heart rate turbulence (HRT) correlated with many previously established prognostic markers of IDC and congestive heart failure, especially measures of cardiorespiratory performance capacity and circulating neurohumoral factors (p < 0.05 for all). Furthermore, attenuated HRV correlated with worse prognosis during a median follow-up of 6.8 years (range 5.1 - 8.1). Additionally, 24-hour time domain, low and high frequency components of frequency domain and non-linear HRV, excluding scaling exponents (α), were lower in IDC patients as compared with controls (p < 0.05 for all); however, HRT was not significantly different. Conclusions: The magnitude of impairment in cardiac autonomic control correlates well with other prognostic markers of IDC, and is associated with unfavorable outcome.

Cite this paper
Kärkkäinen, S. , Puhakka, A. , Fedacko, J. , Magga, J. , Miettinen, K. , Vanninen, E. , Kuusisto, J. , Peuhkurinen, K. and Tuomainen, P. (2015) Cardiac Autonomic Control in Relation to Other Prognostic Markers in Idiopathic Dilated Cardiomyopathy. World Journal of Cardiovascular Diseases, 5, 107-119. doi: 10.4236/wjcd.2015.55014.
References
[1]   Manolio, T.A., Baughman, K.L., Rodeheffer, R., Pearson, T.A., Bristow, J.D., Michels, V.V., et al. (1992) Prevalence and Etiology of Idiopathic Dilated Cardiomyopathy (Summary of a National Heart, Lung, and Blood Institute Workshop). American Journal of Cardiology, 69, 1458-1466.
http://dx.doi.org/10.1016/0002-9149(92)90901-A

[2]   Richardson, P.J. (1996) Assessment of Myocardial Damage in Dilated Cardiomyopathy. European Heart Journal, 17, 489-490.
http://dx.doi.org/10.1093/oxfordjournals.eurheartj.a014894

[3]   Martino, T.A., Liu, P. and Sole, M.J. (1994) Viral Infection and the Pathogenesis of Dilated Cardiomyopathy. Circulation Research, 74, 182-188.
http://dx.doi.org/10.1161/01.RES.74.2.182

[4]   Mestroni, L., Krajinovic, M., Severini, G.M., Milasin, J., Pinamonti, B., Rocco, C., et al. (1995) Molecular Genetics of Dilated Cardiomyopathies. European Heart Journal, 16, 5-9.
http://dx.doi.org/10.1093/eurheartj/16.suppl_O.5

[5]   Calabrese, F. and Thiene, G. (2003) Myocarditis and Inflammatory Cardiomyopathy: Microbiological and Molecular Biological Aspects. Cardiovascular Research, 60, 11-25.
http://dx.doi.org/10.1016/S0008-6363(03)00475-9

[6]   Noutsias, M., Pauschinger, M., Poller, W.C., Schultheiss, H.P. and Kuhl, U. (2003) Current Insights into the Pathogenesis, Diagnosis and Therapy of Inflammatory Cardiomyopathy. Heart Failure Monitoring, 3, 127-135.

[7]   van den Broek, S.A., van Veldhuisen, D.J., de Graeff, P.A., Landsman, M.L., Hillege, H. and Lie, K.I. (1992) Comparison between New York Heart Association Classification and Peak Oxygen Consumption in the Assessment of Functional Status and Prognosis in Patients with Mild to Moderate Chronic Congestive Heart Failure Secondary to Either Ischemic or Idiopathic Dilated Cardiomyopathy. American Journal of Cardiology, 70, 359-363.
http://dx.doi.org/10.1016/0002-9149(92)90619-A

[8]   Cicoira, M., Zanolla, L., Latina, L., Rossi, A., Golia, G., Brighetti, G., et al. (2001) Frequency, Prognosis and Predictors of Improvement of Systolic Left Ventricular Function in Patients with “Classical” Clinical Diagnosis of Idiopathic Dilated Cardiomyopathy. European Journal of Heart Failure, 3, 323-330.
http://dx.doi.org/10.1016/S1388-9842(00)00150-1

[9]   Faris, R., Henein, M.Y. and Coats, A.J. (2003) Ventricular Long Axis Function Is Predictive of Outcome in Patients with Chronic Heart Failure Secondary to Non-Ischemic Dilated Cardiomyopathy. Medical Science Monitor, 9, CR456- CR465.

[10]   Simon, T., Becker, R., Voss, F., Bikou, O., Hauck, M., Licka, M., et al. (2008) Elevated B-Type Natriuretic Peptide Levels in Patients with Nonischemic Cardiomyopathy Predict Occurrence of Arrhythmic Events. Clinical Research in Cardiology, 97, 306-309.
http://dx.doi.org/10.1007/s00392-007-0629-2

[11]   Munger, M.A., Johnson, B., Amber, I.J., Callahan, K.S. and Gilbert, E.M. (1996) Circulating Concentrations of Proinflammatory Cytokines in Mild or Moderate Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy. American Journal of Cardiology, 77, 723-727.
http://dx.doi.org/10.1016/S0002-9149(97)89206-5

[12]   Aukrust, P., Ueland, T., Lien, E., Bendtzen, K., Muller, F., Andreassen, A.K., et al. (1999) Cytokine Network in Congestive Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy. American Journal of Cardiology, 83, 376-382.
http://dx.doi.org/10.1016/S0002-9149(98)00872-8

[13]   Voss, A., Baier, V., Schumann, A., Hasart, A., Reinsperger, F., Schirdewan, A., et al. (2002) Postextrasystolic Regulation Patterns of Blood Pressure and Heart Rate in Patients with Idiopathic Dilated Cardiomyopathy. The Journal of Physiology, 538, 271-278.
http://dx.doi.org/10.1113/jphysiol.2001.013044

[14]   Carvajal, R., Wessel, N., Vallverdu, M., Caminal, P. and Voss, A. (2005) Correlation Dimension Analysis of Heart Rate Variability in Patients with Dilated Cardiomyopathy. Computer Methods and Programs in Biomedicine, 78, 133- 140.
http://dx.doi.org/10.1016/j.cmpb.2005.01.004

[15]   Yi, G., Goldman, J.H., Keeling, P.J., Reardon, M., McKenna, W.J. and Malik, M. (1997) Heart Rate Variability in Idiopathic Dilated Cardiomyopathy: Relation to Disease Severity and Prognosis. Heart, 77, 108-114.
http://dx.doi.org/10.1136/hrt.77.2.108

[16]   Smilde, T.D., van Veldhuisen, D.J. and van den Berg, M.P. (2009) Prognostic Value of Heart Rate Variability and Ventricular Arrhythmias during 13-Year Follow-Up in Patients with Mild to Moderate Heart Failure. Clinical Research in Cardiology, 98, 233-239.
http://dx.doi.org/10.1007/s00392-009-0747-0

[17]   Grimm, W., Christ, M., Bach, J., Muller, H.H. and Maisch, B. (2003) Noninvasive Arrhythmia Risk Stratification in Idiopathic Dilated Cardiomyopathy: Results of the Marburg Cardiomyopathy Study. Circulation, 108, 2883-2891.
http://dx.doi.org/10.1161/01.CIR.0000100721.52503.85

[18]   Fauchier, L., Babuty, D., Cosnay, P. and Fauchier, J.P. (1999) Prognostic Value of Heart Rate Variability for Sudden Death and Major Arrhythmic Events in Patients with Idiopathic Dilated Cardiomyopathy. Journal of the American College of Cardiology, 33, 1203-1207.
http://dx.doi.org/10.1016/S0735-1097(99)00021-2

[19]   Rashba, E.J., Estes, N.A., Wang, P., Schaechter, A., Howard, A., Zareba, W., et al. (2006) Preserved Heart Rate Variability Identifies Low-Risk Patients with Nonischemic Dilated Cardiomyopathy: Results from the DEFINITE Trial. Heart Rhythm, 3, 281-286.
http://dx.doi.org/10.1016/j.hrthm.2005.11.028

[20]   Simon, T., Becker, R., Voss, F., Bikou, O., Hauck, M., Licka, M., Katus, H.A. and Bauer, A. (2008) Elevated B-Type Natriuretic Peptide Levels in Patients with Nonischemic Cardiomyopathy Predict Occurrence of Arrhythmic Events. Clinical Research in Cardiology, 97, 306-309.
http://dx.doi.org/10.1007/s00392-007-0629-2

[21]   Tuomainen, P., Hartikainen, J., Vanninen, E. and Peuhkurinen, K. (2005) Warm-Up Phenomenon and Cardiac Autonomic Control in Patients with Coronary Artery Disease. Life Sciences, 76, 2147-2158.
http://dx.doi.org/10.1016/j.lfs.2004.06.033

[22]   Tuomainen, P., Peuhkurinen, K., Kettunen, R. and Rauramaa, R. (2005) Regular Physical Exercise, Heart Rate Variability and Turbulence in a 6-Year Randomized Controlled Trial in Middle-Aged Men: The DNASCO Study. Life Sciences, 77, 2723-2734.
http://dx.doi.org/10.1016/j.lfs.2005.05.023

[23]   Schmidt, G., Malik, M., Barthel, P., Schneider, R., Ulm, K., Rolnitzky, L., et al. (1999) Heart-Rate Turbulence after Ventricular Premature Beats as a Predictor of Mortality after Acute Myocardial Infarction. The Lancet, 353, 1390-1396.
http://dx.doi.org/10.1016/S0140-6736(98)08428-1

[24]   Tuomainen, P.O., Magga, J., Timonen, P., Miettinen, K., Kurttila, M., Vanninen, E., Laitinen, T., Timonen, K., Punnonen, K., Parviainen, I., Uusaro, A., Vuolteenaho, O., Kivikko, M. and Peuhkurinen, K. (2013) Intermittent Levosimendan Treatment in Patients with Severe Congestive Heart Failure. Clinical Research in Cardiology, 102, 485-493.
http://dx.doi.org/10.1007/s00392-013-0554-5

[25]   Tuomainen, P.O., Magga, J., Fedacko, J., Karkkainen, S., Miettinen, K., Vanninen, E., Kuusisto, J. and Peuhkurinen, K.J. (2014) Idiopathic Dilated Cardiomyopathy and Chromic Atrial Fibrillation. Clinical Physiology and Functional Imaging, 34, 133-137.
http://dx.doi.org/10.1111/cpf.12075

[26]   La Rovere, M., Pinna, G., Maestri, R., Barlera, S., Bernardinangeli, M., Veniani, M., et al. (2012) Autonomic Markers and Cardiovascular and Arrhythmic Events in Heart Failure Patients: Still a Place in Prognostication? Data from the GISSI-HF Trial. European Journal of Heart Failure, 14, 1410-1419.
http://dx.doi.org/10.1093/eurjhf/hfs126

[27]   Baldasseroni, S., Opasich, C., Gorini, M., Lucci, D., Marchionni, N., Marini, M., et al. (2002) Left Bundle-Branch Block Is Associated with Increased 1-Year Sudden and Total Mortality Rate in 5517 Outpatients with Congestive Heart Failure: A Report from the Italian Network on Congestive Heart Failure. American Heart Journal, 143, 398-405.
http://dx.doi.org/10.1067/mhj.2002.121264

[28]   Hofmann, T., Meinertz, T., Kasper, W., Geibel, A., Zehender, M., Hohnloser, S., Stienen, U., Treese, N. and Just, H. (1988) Mode of Death in Idiopathic Dilated Cardiomyopathy: A Multivariate Analysis of Prognostic Determinants. American Heart Journal, 116, 1455-1463.
http://dx.doi.org/10.1016/0002-8703(88)90728-4

[29]   Ahmad, S., Otaal, P.S., Rai, T.S., Bahl, A., Saikia, U.N., Manoj, R.K., Thungapathra, M., Talwar, K.K. and Khullar, M. (2009) Circulating Proinflammatory Cytokines and N-Terminal Pro-Brain Natriuretic Peptide Significantly Decrease with Recovery of Left Ventricular Function in Patients with Dilated Cardiomyopathy. Molecular and Cellular Biochemistry, 324, 139-145.
http://dx.doi.org/10.1007/s11010-008-9992-1

[30]   Gulati, A., Ismail, T.F., Jabbour, A., Ismail, N.A., Morarji, K., Ali, A., Raza, S., Khwaja, J., et al. (2013) Clinical Utility and Prognostic Value of Left Atrial Volume Assessment by Cardiovascular Magnetic Resonance in Non-Ischaemic Dilated Cardiomyopathy. European Journal of Heart Failure, 15, 660-670.
http://dx.doi.org/10.1093/eurjhf/hft019

[31]   Sugrue, D.D., Rodeheffer, R.J., Codd, M.B., Ballard, D.J., Fuster, V. and Gersh, B.J. (1992) The Clinical Course of Idiopathic Dilated Cardiomyopathy: A Population-Based Study. Annals of Internal Medicine, 117, 117-123.
http://dx.doi.org/10.7326/0003-4819-117-2-117

[32]   Schefer, T., Wolber, T., Binggeli, C., Holzmeister, J., Brunckhorst, C. and Duru, F. (2008) Long-Term Predictors of Mortality in ICD Patients with Non-Ischaemic Cardiac Disease: Impact of Renal Function. Europace, 10, 1052-1059.
http://dx.doi.org/10.1093/europace/eun186

[33]   Grimm, W., Hoffmann, J., Menz, V., Luck, K. and Maisch, B. (1998) Programmed Ventricular Stimulation for Arrhythmia Risk Prediction in Patients with Idiopathic Dilated Cardiomyopathy and Nonsustained Ventricular Tachycardia. Journal of the American College of Cardiology, 32, 739-745.
http://dx.doi.org/10.1016/S0735-1097(98)00306-4

[34]   Lau, E.W., Griffith, M.J., Pathmanathan, R.K., Ng, G.A., Clune, M.M., Cooper, J., et al. (2004) The Midlands Trial of Empirical Amiodarone versus Electrophysiology-Guided Interventions and Implantable Cardioverter-Defibrillators (MAVERIC): A Multi-Centre Prospective Randomised Clinical Trial on the Secondary Prevention of Sudden Cardiac Death. Europace, 6, 257-266.
http://dx.doi.org/10.1016/j.eupc.2004.03.009

[35]   European Society of Cardiology, Heart Failure Association of the ESC (HFA), European Society of Intensive Care Medicine (ESICM), Dickstein, K., Cohen-Solal, A., Filippatos, G., et al. (2008) ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in Collaboration with the Heart Failure Association of the ESC (HFA) and Endorsed by the European Society of Intensive Care Medicine (ESICM). European Journal of Heart Failure, 10, 933-989.

[36]   Binkley, P.F., Haas, G.J., Starling, R.C., Nunziata, E., Hatton, P.A., Leier, C.V., et al. (1993) Sustained Augmentation of Parasympathetic Tone with Angiotensin-Converting Enzyme Inhibition in Patients with Congestive Heart Failure. Journal of the American College of Cardiology, 21, 655-661.
http://dx.doi.org/10.1016/0735-1097(93)90098-L

[37]   Niemela, M.J., Airaksinen, K.E. and Huikuri, H.V. (1994) Effect of Beta-Blockade on Heart Rate Variability in Patients with Coronary Artery Disease. Journal of the American College of Cardiology, 23, 1370-1377.
http://dx.doi.org/10.1016/0735-1097(94)90379-4

[38]   Wilkins, M.R., Redondo, J. and Brown, L.A. (1997) The Natriuretic-Peptide Family. The Lancet, 349, 1307-1310.
http://dx.doi.org/10.1016/S0140-6736(96)07424-7

[39]   Vanderheyden, M., Goethals, M., Verstreken, S., De Bruyne, B., Muller, K., Van Schuerbeeck, E., et al. (2004) Wall Stress Modulates Brain Natriuretic Peptide Production in Pressure Overload Cardiomyopathy. Journal of the American College of Cardiology, 44, 2349-2354.
http://dx.doi.org/10.1016/j.jacc.2004.09.038

[40]   Iwanaga, Y., Nishi, I., Furuichi, S., Noguchi, T., Sase, K., Kihara, Y., et al. (2006) B-Type Natriuretic Peptide Strongly Reflects Diastolic Wall Stress in Patients with Chronic Heart Failure: Comparison between Systolic and Diastolic Heart Failure. Journal of the American College of Cardiology, 47, 742-748.
http://dx.doi.org/10.1016/j.jacc.2005.11.030

[41]   Adamson, P.B., Kleckner, K.J., Van Hout, W.L., Srinivasan, S. and Abraham, W.T. (2003) Cardiac Resynchronization Therapy Improves Heart Rate Variability in Patients with Symptomatic Heart Failure. Circulation, 108, 266-269.
http://dx.doi.org/10.1161/01.CIR.0000083368.75831.7A

[42]   Gademan, M.G., van Bommel, R.J., Ypenburg, C., Haest, J.C., Schalij, M.J., van der Wall, E.E., et al. (2008) Biventricular Pacing in Chronic Heart Failure Acutely Facilitates the Arterial Baroreflex. AJP: Heart and Circulatory Physiology, 295, H755-H760.
http://dx.doi.org/10.1152/ajpheart.00170.2008

[43]   Machado, C.R., Camargos, E.R., Guerra, L.B. and Moreira, M.C. (2000) Cardiac Autonomic Denervation in Congestive Heart Failure: Comparison of Chagas’ Heart Disease with Other Dilated Cardiomyopathy. Human Pathology, 31, 3-10.
http://dx.doi.org/10.1016/S0046-8177(00)80191-4

[44]   Rutschow, S., Li, J., Schultheiss, H.P. and Pauschinger, M. (2006) Myocardial Proteases and Matrix Remodeling in Inflammatory Heart Disease. Cardiovascular Research, 69, 646-656.
http://dx.doi.org/10.1016/j.cardiores.2005.12.009

[45]   Miettinen, K.H., Eriksson, S., Magga, J., Tuomainen, P., Kuusisto, J., Vanninen, E.J., et al. (2008) Clinical Significance of Troponin I Efflux and Troponin Autoantibodies in Patients with Dilated Cardiomyopathy. Journal of Cardiac Failure, 14, 481-488.
http://dx.doi.org/10.1016/j.cardfail.2008.02.009

[46]   Francis, J., Zhang, Z.H., Weiss, R.M. and Felder, R.B. (2004) Neural Regulation of the Proinflammatory Cytokine Response to Acute Myocardial Infarction. AJP: Heart and Circulatory Physiology, 287, H791-H797.
http://dx.doi.org/10.1152/ajpheart.00099.2004

 
 
Top